Quadrant HealthCom buys Dowden journals

Share this article:

Quadrant HealthCom purchased the journals division of Dowden Health Media from Lebhar-Friedman. Terms of the deal were not disclosed.

The transaction, brokered by media bankers Desilva + Phillips, closed yesterday. It gives Quadrant HealthCom four Dowden Professional Publications journals – OBG Management, Current Psychiatry, The Journal of Family Practice and Mayo Clinic Proceedings – along with Dowden's events division. About 30 Dowden employees will relocate to Quadrant's headquarters in Parsippany, NJ.

Quadrant president Stephen Stoneburn said in a statement: “We are excited about the opportunity to add leading properties in new therapeutic and audience markets and to expand our already strong presence in the women's healthcare sector.”

Quadrant's stable of nine journals includes The Female Patient.

Lebhar-Friedman acquired Dowden in 2005, and is keeping Dowden's hospital marketing group and medical education business.

Lebhar-Friedman president Roger Friedman said that with the dropoff in journal ad pages and numerous blockbusters losing patent protection in the next few years, his company was looking for less exposure to advertising-dependent businesses. "We wanted to get away from products that were strictly advertising-based, and the professional journals group at Dowden was almost entirely advertising-based," said Friedman. "We'd rather be in databases, research, education -- more proprietary products."

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in News

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.